Subscribe Sign In Register

Premium

In a Tough Year, Viking Global Stages an October Comeback

Three major funds help put the firm in the black, despite a major bet on ravaged health care stocks, including Valeant Pharmaceuticals.

By Stephen Taub Stephen Taub
November 4, 2015

andreas-halvorsen.jpg
O. Andreas Halvorsen, Viking Global Investors (Bloomberg)

Viking Global Investors posted decent gains across all three of its funds in October.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Viking Global Investors O Andreas Halvorsen
Related
Art_ThirdPointAlphabet_0207.jpg
Portfolio
Third Point Takes Large Stake in Alphabet (Again)
Stephen Taub
February 6, 2024
art_google072623.jpg
Premium
Hedge Funds That Sold Alphabet Miss Out on Huge Gains
Stephen Taub
July 27, 2023
Book with title private equity and calculator.
Sponsored
An Introduction to Private Equity Basics